5 GAME-CHANGERS IN SA HEALTH
THE MYGENERX TEST: MEDICATION WITH NO SIDE-EFFECTS
We take the side-effects of medication as a given when, in reality, there are a variety of drugs available and not all of them cause sideeffects in all of us. The missing link to understanding which medication is best suited to an individual’s needs is now a genetic test away.
DNAlysis Biotechnology has developed a DNA test called mygeneRx. It allows doctors to prescribe medication that is suited to each patient’s unique genetic make-up – mitigating the risk of side-effects.
We spoke to Danny Meyersfield, the CEO of DNAlysis Biotechnology, to understand the groundbreaking implications of this technology.
WHERE DID THE VISION FOR MYGENERX COME FROM?
“Since its inception, almost 10 years ago, DNAlysis has focused exclusively on the field of nutrigenomics, assisting healthcare practitioners in providing personalised nutrition and lifestyle advice based on a genetic test. We have always been mindful of the clinical benefits and potential cost savings inherent in pharmacogenetic testing, and so it was only a matter of time before we were going to launch this test.”
WHAT MOTIVATED YOU TO PUT THIS IDEA INTO ACTION?
“The availability of cloud-based interpretation and reporting systems, combined with DNAlysis upscaling the laboratory infrastructure, meant that the time was appropriate to launch this test into the South African market.”
HOW DOES MYGENERX DELIVER ON THIS PROMISE?
The mygeneRx test ensures that:
• Patients are
